A detailed history of Glenview Capital Management, LLC transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Glenview Capital Management, LLC holds 500,000 shares of BLCO stock, worth $5.7 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
500,000
Holding current value
$5.7 Million
% of portfolio
0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$14.13 - $18.15 $7.07 Million - $9.08 Million
500,000 New
500,000 $7.25 Million
Q3 2022

Nov 14, 2022

BUY
$14.23 - $17.76 $21.6 Million - $26.9 Million
1,516,684 New
1,516,684 $23.3 Million

Others Institutions Holding BLCO

About Bausch & Lomb Corp


  • Ticker BLCO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 350,000,000
  • Market Cap $3.99B
  • Description
  • Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...
More about BLCO
Track This Portfolio

Track Glenview Capital Management, LLC Portfolio

Follow Glenview Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Capital Management, LLC with notifications on news.